Sequent Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $210K | Buy |
+835
| New | +$180K | 0.09% | 89 |
|
|
2023
Q2 | – | Sell |
-2,217
| Closed | -$354K | – | 54 |
|
|
2023
Q1 | $354K | Sell |
2,217
-94
| -4% | -$14.4K | 0.4% | 42 |
|
|
2022
Q4 | $374K | Hold |
2,311
| – | – | 0.25% | 47 |
|
|
2022
Q3 | $311K | Hold |
2,311
| – | – | 0.23% | 53 |
|
|
2022
Q2 | $354K | Buy |
2,311
+45
| +2% | +$6.88K | 0.26% | 51 |
|
|
2022
Q1 | $368K | Sell |
2,266
-131
| -5% | -$19K | 0.22% | 56 |
|
|
2021
Q4 | $325K | Buy |
+2,397
| New | +$283K | 0.18% | 60 |
|
|
2020
Q4 | – | Sell |
-6,425
| Closed | -$563K | – | 63 |
|
|
2020
Q3 | $563K | Hold |
6,425
| – | – | 0.41% | 42 |
|
|
2020
Q2 | $631K | Hold |
6,425
| – | – | 0.48% | 41 |
|
|
2020
Q1 | $490K | Hold |
6,425
| – | – | 0.4% | 41 |
|
|
2019
Q4 | $569K | Hold |
6,425
| – | – | 0.33% | 45 |
|
|
2019
Q3 | $487K | Hold |
6,425
| – | – | 0.36% | 38 |
|
|
2019
Q2 | $467K | Sell |
6,425
-1,125
| -15% | -$88.4K | 0.34% | 39 |
|
|
2019
Q1 | $608K | Hold |
7,550
| – | – | 0.44% | 34 |
|
|
2018
Q4 | $696K | Hold |
7,550
| – | – | 0.56% | 29 |
|
|
2018
Q3 | $714K | Hold |
7,550
| – | – | 0.49% | 30 |
|
|
2018
Q2 | $700K | Hold |
7,550
| – | – | 0.49% | 30 |
|
|
2018
Q1 | $492K | Hold |
7,550
| – | – | 0.3% | 50 |
|
|
2017
Q4 | $730K | Hold |
7,550
| – | – | 0.4% | 41 |
|
|
2017
Q3 | $671K | Hold |
7,550
| – | – | 0.39% | 42 |
|
|
2017
Q2 | $547K | Hold |
7,550
| – | – | 0.33% | 48 |
|
|
2017
Q1 | $492K | Hold |
7,550
| – | – | 0.28% | 52 |
|
|
2016
Q4 | $473K | Hold |
7,550
| – | – | 0.29% | 43 |
|
|
2016
Q3 | $477K | Hold |
7,550
| – | – | 0.31% | 43 |
|
|
2016
Q2 | $467K | Hold |
7,550
| – | – | 0.31% | 45 |
|
|
2016
Q1 | $431K | Sell |
7,550
-600
| -7% | -$33.4K | 0.29% | 47 |
|
|
2015
Q4 | $483K | Hold |
8,150
| – | – | 0.35% | 44 |
|
|
2015
Q3 | $444K | Hold |
8,150
| – | – | 0.34% | 54 |
|
|
2015
Q2 | $548K | Hold |
8,150
| – | – | 0.38% | 53 |
|
|
2015
Q1 | $477K | Sell |
8,150
-21,245
| -72% | -$1.28M | 0.34% | 53 |
|
|
2014
Q4 | $1.92M | Hold |
29,395
| – | – | 1.39% | 15 |
|
|
2014
Q3 | $1.7M | Sell |
29,395
-720
| -2% | -$40K | 1.28% | 17 |
|
|
2014
Q2 | $1.7M | Sell |
30,115
-300
| -1% | -$15.7K | 1.23% | 16 |
|
|
2014
Q1 | $1.56M | Sell |
30,415
-4,555
| -13% | -$230K | 1.24% | 17 |
|
|
2013
Q4 | $1.85M | Sell |
34,970
-800
| -2% | -$39.3K | 1.56% | 14 |
|
|
2013
Q3 | $1.6M | Buy |
35,770
+6,166
| +21% | +$273K | 1.46% | 16 |
|
|
2013
Q2 | $1.22M | Buy |
+29,604
| New | +$1.29M | 1.43% | 15 |
|
Other funds holding ABBV
ECSS
ATO
Sequent Asset Management's ABBV Position: Q2 2026 in Review
Sequent Asset Management opened a new position in AbbVie (ABBV) in Q2 2026: 835 shares worth $210K. The stake represents 0.09% of the portfolio and ranks #89 among its holdings. This is a return to the name: Sequent Asset Management previously reported a position in ABBV as recently as Q1 2023.
Sequent Asset Management first reported a position in ABBV in Q2 2013 and has held it in 37 quarters since. The position peaked at $1.92M in Q4 2014. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Sequent Asset Management held 835 shares of AbbVie worth $210K as of Q2 2026.
- AbbVie was a new Sequent Asset Management position in Q2 2026.
- AbbVie made up 0.09% of Sequent Asset Management's portfolio in Q2 2026, its #89 holding.
- Sequent Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 37 quarters since.
- Sequent Asset Management's AbbVie position peaked at $1.92M in Q4 2014.
- 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Sequent Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.